Zobrazeno 1 - 10
of 77 188
pro vyhledávání: '"drug approval"'
Autor:
Rim MH; Northwestern Medicine, Chicago, IL, USA., Dean C; Northwestern Medicine, Chicago, IL, USA., Aliaj E; Northwestern Medicine, Chicago, IL, USA., Karas BL; Northwestern Medicine, Chicago, IL, USA., Barada F; Northwestern Medicine, Chicago, IL, USA., Levitsky AM; IPD Analytics, Aventura, FL, USA.
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2024 Nov 07; Vol. 81 (22), pp. 1103-1108.
Autor:
Martínez-Barros H; Servicio de Farmacia, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, España. Electronic address: hilario.martinez@salud.madrid.org., Pousada-Fonseca Á; Servicio de Farmacia, Hospital Universitario de Móstoles, Madrid, España., Pedreira-Bouzas J; Servicio de Farmacia, Hospital Universitario de Fuenlabrada, Madrid, España., Clopés-Estela A; Servicio de Farmacia, Instituto Catalán de Oncología (ICO), Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Universidad Ramon Llull, Barcelona, España.
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Nov-Dec; Vol. 48 (6), pp. 272-277. Date of Electronic Publication: 2024 May 25.
Autor:
Martínez-Barros H; Servicio de Farmacia, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. Electronic address: hilario.martinez@salud.madrid.org., Pousada-Fonseca Á; Servicio de Farmacia, Hospital Universitario de Móstoles, Madrid, Spain., Pedreira-Bouzas J; Servicio de Farmacia, Hospital Universitario de Fuenlabrada, Madrid, Spain., Clopés-Estela A; Servicio de Farmacia, Instituto Catalán de Oncología (ICO) t, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Universidad Ramon Llull, Barcelona, Spain.
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Nov-Dec; Vol. 48 (6), pp. T272-T277. Date of Electronic Publication: 2024 Jul 27.
Autor:
Mangia F; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland. francesca.mangia@roche.com., Lin YM; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland., Armando J; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Dominguez K; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland., Rozhnova V; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland., Ausborn S; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Nov; Vol. 58 (6), pp. 997-1005. Date of Electronic Publication: 2024 Jul 24.
Autor:
Daval CJR; From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston., Kesselheim AS; From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston., Cliff ERS; From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Oct 10; Vol. 391 (14), pp. 1273-1275. Date of Electronic Publication: 2024 Oct 05.
Autor:
Schuhmacher A; Technische Hochschule Ingolstadt, THI Business School, Esplanade 10, D-85049 Ingolstadt, Germany; University of St. Gallen, Institute of Technology Management, Dufourstrasse 40a, CH-9000 St. Gallen, Switzerland. Electronic address: alexander.schuhmacher@thi.de., Gassmann O; University of St. Gallen, Institute of Technology Management, Dufourstrasse 40a, CH-9000 St. Gallen, Switzerland., Hinder M; Novartis, Development, Patient Safety, Forum 1, CH-4002 Basel, Switzerland; Fresenius University of Applied Sciences, Moritzstr. 17a, D-65185 Wiesbaden, Germany., Hartl D; University of Tübingen, Hoppe-Seyler-Strasse 1, D-72076 Tübingen, Germany; Granite Bio, Aeschenvorstadt 36, CH-4051 Basel, Switzerland.
Publikováno v:
Drug discovery today [Drug Discov Today] 2024 Sep; Vol. 29 (9), pp. 104128. Date of Electronic Publication: 2024 Aug 05.
Autor:
Held L; Epidemiology, Biostatistics and Prevention Institute (EBPI) and Center for Reproducible Science (CRS), University of Zurich, Zurich, Switzerland.
Publikováno v:
Statistics in medicine [Stat Med] 2024 Nov 20; Vol. 43 (26), pp. 5023-5042. Date of Electronic Publication: 2024 Apr 04.
Autor:
Fallah J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Heiss BL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Joeng HK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Weinstock C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gao X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pierce WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Chukwurah B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bhatnagar V; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Fiero MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Suzman DL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Nov 15; Vol. 30 (22), pp. 5003-5008.
Autor:
Kuribayashi R; Office of Cellular and Tissue-Based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-Ku, Tokyo, 100-0013, Japan. kuribayashi-ryosuke@pmda.go.jp.; Office of Regulatory Science Research, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-Ku, Tokyo, 100-0013, Japan. kuribayashi-ryosuke@pmda.go.jp., Goto K; Office of Cellular and Tissue-Based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-Ku, Tokyo, 100-0013, Japan., Ogawa T; Office of Generic Drugs, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-Ku, Tokyo, 100-0013, Japan.
Publikováno v:
The AAPS journal [AAPS J] 2024 Nov 12; Vol. 26 (6), pp. 113. Date of Electronic Publication: 2024 Nov 12.
Autor:
Mao X; Vanke School of Public Health, Tsinghua University, Beijing, China; Institute for Healthy China, Tsinghua University, Beijing, China., Alexander GC; Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Li G; Vanke School of Public Health, Tsinghua University, Beijing, China; Institute for Healthy China, Tsinghua University, Beijing, China. Electronic address: guanqiaoli@tsinghua.edu.cn.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Nov 11; Vol. 42 (11), pp. 1799-1802. Date of Electronic Publication: 2024 Oct 10.